Brief: Kimia Biosciences Received Approval Of Advance Authorisation License Of Gliclazide BP An API
07/03/2023 07:47
March 7 (Reuters) - Kimia Biosciences Ltd KIMI.BO :
* CO RECEIVED APPROVAL OF ADVANCE AUTHORISATION LICENSE OF
GLICLAZIDE BP AN API
* APPROVAL FROM DIRECTORATE GENERAL OF FOREIGN TRADE
Source text for Eikon: ID:nBSE8TRQFP
Further company coverage: KIMI.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kimia Biosciences
See all newsBrief: Kimia Biosciences Ltd Says Naveen Sharma Resigns As CFO
Brief: Kimia Biosciences Appoints Naveen Sharma As CFO
Brief: Kimia Biosciences Pradip Kumar Sharma Resigns as Chief Financial Officer
Brief: Kimia Biosciences Says Rakesh Chetani Resigns As CFO
Brief: Kimia Biosciences Gets Order Worth $200,000